Shingles Vaccine Market Size, Trends, Analysis, and Outlook By Product (Shingrix, Zostavax, SKYZoster), By Type (Recombinant Vaccine, Live Attenuated Vaccine), by Region, Country, Segment, and Companies, 2024-2030
The global Shingles Vaccine market size is poised to register 8.74% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Shingles Vaccine market across By Product (Shingrix, Zostavax, SKYZoster), By Type (Recombinant Vaccine, Live Attenuated Vaccine).
The Shingles Vaccine market is experiencing significant growth, driven by the aging population, the high burden of herpes zoster infection, and the availability of safe and effective vaccines for preventing shingles and its complications. Shingles, caused by the reactivation of the varicella-zoster virus, can lead to debilitating pain, rash, and long-term nerve damage, particularly in older adults and immunocompromised individuals. Vaccination against shingles has been shown to reduce the incidence and severity of the disease, offering protection against postherpetic neuralgia and other complications. With increasing vaccination coverage, public health campaigns, and the introduction of new vaccines with improved efficacy and safety profiles, the market for shingles vaccines is expected to witness continued expansion, contributing to the prevention of shingles-related morbidity and mortality.
Shingles Vaccine Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Shingles Vaccine market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Shingles Vaccine survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Shingles Vaccine industry.
Key market trends defining the global Shingles Vaccine demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Shingles Vaccine Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Shingles Vaccine industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Shingles Vaccine companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Shingles Vaccine industry
Leading Shingles Vaccine companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Shingles Vaccine companies.
Shingles Vaccine Market Study- Strategic Analysis Review
The Shingles Vaccine market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Shingles Vaccine industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Shingles Vaccine Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Shingles Vaccine Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Shingles Vaccine market segments. Similarly, Strong end-user demand is encouraging Canadian Shingles Vaccine companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Shingles Vaccine market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Shingles Vaccine Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Shingles Vaccine industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Shingles Vaccine market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Shingles Vaccine Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Shingles Vaccine in Asia Pacific. In particular, China, India, and South East Asian Shingles Vaccine markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Shingles Vaccine Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Shingles Vaccine Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Shingles Vaccine market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Shingles Vaccine.
Shingles Vaccine Market Company Profiles
The global Shingles Vaccine market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are CanSinoBIO, Changchun BCHT Biotechnology Co, Curevo Inc, Geneone Life Science, GSK plc, Jiangsu Recbio Technology Co. Ltd, Merck & Co. Inc, Pfizer Inc, SK chemicals, Vaccitech
Recent Shingles Vaccine Market Developments
The global Shingles Vaccine market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Shingles Vaccine Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Shingrix
Zostavax
SKYZoster
By Type
Recombinant Vaccine
Live Attenuated Vaccine
Geographical Segmentation:
CanSinoBIO
Changchun BCHT Biotechnology Co
Curevo Inc
Geneone Life Science
GSK plc
Jiangsu Recbio Technology Co. Ltd
Merck & Co. Inc
Pfizer Inc
SK chemicals
Vaccitech
Formats Available: Excel, PDF, and PPT
The Shingles Vaccine market is experiencing significant growth, driven by the aging population, the high burden of herpes zoster infection, and the availability of safe and effective vaccines for preventing shingles and its complications. Shingles, caused by the reactivation of the varicella-zoster virus, can lead to debilitating pain, rash, and long-term nerve damage, particularly in older adults and immunocompromised individuals. Vaccination against shingles has been shown to reduce the incidence and severity of the disease, offering protection against postherpetic neuralgia and other complications. With increasing vaccination coverage, public health campaigns, and the introduction of new vaccines with improved efficacy and safety profiles, the market for shingles vaccines is expected to witness continued expansion, contributing to the prevention of shingles-related morbidity and mortality.
Shingles Vaccine Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Shingles Vaccine market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Shingles Vaccine survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Shingles Vaccine industry.
Key market trends defining the global Shingles Vaccine demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Shingles Vaccine Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Shingles Vaccine industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Shingles Vaccine companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Shingles Vaccine industry
Leading Shingles Vaccine companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Shingles Vaccine companies.
Shingles Vaccine Market Study- Strategic Analysis Review
The Shingles Vaccine market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Shingles Vaccine industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Shingles Vaccine Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Shingles Vaccine Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Shingles Vaccine market segments. Similarly, Strong end-user demand is encouraging Canadian Shingles Vaccine companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Shingles Vaccine market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Shingles Vaccine Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Shingles Vaccine industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Shingles Vaccine market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Shingles Vaccine Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Shingles Vaccine in Asia Pacific. In particular, China, India, and South East Asian Shingles Vaccine markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Shingles Vaccine Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Shingles Vaccine Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Shingles Vaccine market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Shingles Vaccine.
Shingles Vaccine Market Company Profiles
The global Shingles Vaccine market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are CanSinoBIO, Changchun BCHT Biotechnology Co, Curevo Inc, Geneone Life Science, GSK plc, Jiangsu Recbio Technology Co. Ltd, Merck & Co. Inc, Pfizer Inc, SK chemicals, Vaccitech
Recent Shingles Vaccine Market Developments
The global Shingles Vaccine market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Shingles Vaccine Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Shingrix
Zostavax
SKYZoster
By Type
Recombinant Vaccine
Live Attenuated Vaccine
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
CanSinoBIO
Changchun BCHT Biotechnology Co
Curevo Inc
Geneone Life Science
GSK plc
Jiangsu Recbio Technology Co. Ltd
Merck & Co. Inc
Pfizer Inc
SK chemicals
Vaccitech
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Shingles Vaccine Market Overview and Key Findings, 2024
1.2 Shingles Vaccine Market Size and Growth Outlook, 2021- 2030
1.3 Shingles Vaccine Market Growth Opportunities to 2030
1.4 Key Shingles Vaccine Market Trends and Challenges
1.4.1 Shingles Vaccine Market Drivers and Trends
1.4.2 Shingles Vaccine Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Shingles Vaccine Companies
2. SHINGLES VACCINE MARKET SIZE OUTLOOK TO 2030
2.1 Shingles Vaccine Market Size Outlook, USD Million, 2021- 2030
2.2 Shingles Vaccine Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. SHINGLES VACCINE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. SHINGLES VACCINE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Shingrix
Zostavax
SKYZoster
By Type
Recombinant Vaccine
Live Attenuated Vaccine
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Shingles Vaccine Market, 2025
5.2 Asia Pacific Shingles Vaccine Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Shingles Vaccine Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Shingles Vaccine Market, 2025
5.5 Europe Shingles Vaccine Market Size Outlook by Type, 2021- 2030
5.6 Europe Shingles Vaccine Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Shingles Vaccine Market, 2025
5.8 North America Shingles Vaccine Market Size Outlook by Type, 2021- 2030
5.9 North America Shingles Vaccine Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Shingles Vaccine Market, 2025
5.11 South America Pacific Shingles Vaccine Market Size Outlook by Type, 2021- 2030
5.12 South America Shingles Vaccine Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Shingles Vaccine Market, 2025
5.14 Middle East Africa Shingles Vaccine Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Shingles Vaccine Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Shingles Vaccine Market Size Outlook and Revenue Growth Forecasts
6.2 US Shingles Vaccine Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Shingles Vaccine Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Shingles Vaccine Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Shingles Vaccine Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Shingles Vaccine Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Shingles Vaccine Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Shingles Vaccine Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Shingles Vaccine Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Shingles Vaccine Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Shingles Vaccine Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Shingles Vaccine Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Shingles Vaccine Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Shingles Vaccine Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Shingles Vaccine Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Shingles Vaccine Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Shingles Vaccine Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Shingles Vaccine Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Shingles Vaccine Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Shingles Vaccine Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Shingles Vaccine Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Shingles Vaccine Industry Drivers and Opportunities
7. SHINGLES VACCINE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. SHINGLES VACCINE COMPANY PROFILES
8.1 Profiles of Leading Shingles Vaccine Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
CanSinoBIO
Changchun BCHT Biotechnology Co
Curevo Inc
Geneone Life Science
GSK plc
Jiangsu Recbio Technology Co. Ltd
Merck & Co. Inc
Pfizer Inc
SK chemicals
Vaccitech
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Shingles Vaccine Market Overview and Key Findings, 2024
1.2 Shingles Vaccine Market Size and Growth Outlook, 2021- 2030
1.3 Shingles Vaccine Market Growth Opportunities to 2030
1.4 Key Shingles Vaccine Market Trends and Challenges
1.4.1 Shingles Vaccine Market Drivers and Trends
1.4.2 Shingles Vaccine Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Shingles Vaccine Companies
2. SHINGLES VACCINE MARKET SIZE OUTLOOK TO 2030
2.1 Shingles Vaccine Market Size Outlook, USD Million, 2021- 2030
2.2 Shingles Vaccine Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. SHINGLES VACCINE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. SHINGLES VACCINE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Shingrix
Zostavax
SKYZoster
By Type
Recombinant Vaccine
Live Attenuated Vaccine
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Shingles Vaccine Market, 2025
5.2 Asia Pacific Shingles Vaccine Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Shingles Vaccine Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Shingles Vaccine Market, 2025
5.5 Europe Shingles Vaccine Market Size Outlook by Type, 2021- 2030
5.6 Europe Shingles Vaccine Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Shingles Vaccine Market, 2025
5.8 North America Shingles Vaccine Market Size Outlook by Type, 2021- 2030
5.9 North America Shingles Vaccine Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Shingles Vaccine Market, 2025
5.11 South America Pacific Shingles Vaccine Market Size Outlook by Type, 2021- 2030
5.12 South America Shingles Vaccine Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Shingles Vaccine Market, 2025
5.14 Middle East Africa Shingles Vaccine Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Shingles Vaccine Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Shingles Vaccine Market Size Outlook and Revenue Growth Forecasts
6.2 US Shingles Vaccine Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Shingles Vaccine Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Shingles Vaccine Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Shingles Vaccine Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Shingles Vaccine Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Shingles Vaccine Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Shingles Vaccine Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Shingles Vaccine Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Shingles Vaccine Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Shingles Vaccine Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Shingles Vaccine Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Shingles Vaccine Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Shingles Vaccine Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Shingles Vaccine Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Shingles Vaccine Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Shingles Vaccine Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Shingles Vaccine Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Shingles Vaccine Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Shingles Vaccine Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Shingles Vaccine Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Shingles Vaccine Industry Drivers and Opportunities
7. SHINGLES VACCINE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. SHINGLES VACCINE COMPANY PROFILES
8.1 Profiles of Leading Shingles Vaccine Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
CanSinoBIO
Changchun BCHT Biotechnology Co
Curevo Inc
Geneone Life Science
GSK plc
Jiangsu Recbio Technology Co. Ltd
Merck & Co. Inc
Pfizer Inc
SK chemicals
Vaccitech
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
